These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 18208799)
1. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis. Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799 [TBL] [Abstract][Full Text] [Related]
2. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315 [TBL] [Abstract][Full Text] [Related]
3. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs. Gradowski JF; Mantha GS; Hunt JL; Dacic S Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677 [TBL] [Abstract][Full Text] [Related]
4. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung. Morandi L; Asioli S; Cavazza A; Pession A; Damiani S Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687 [TBL] [Abstract][Full Text] [Related]
5. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325 [TBL] [Abstract][Full Text] [Related]
6. The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. Cooper CA; Carby FA; Bubb VJ; Lamb D; Kerr KM; Wyllie AH J Pathol; 1997 Apr; 181(4):401-4. PubMed ID: 9196437 [TBL] [Abstract][Full Text] [Related]
7. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas. Shigematsu H; Takahashi T; Nomura M; Majmudar K; Suzuki M; Lee H; Wistuba II; Fong KM; Toyooka S; Shimizu N; Fujisawa T; Minna JD; Gazdar AF Cancer Res; 2005 Mar; 65(5):1642-6. PubMed ID: 15753357 [TBL] [Abstract][Full Text] [Related]
8. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression. Willmore-Payne C; Holden JA; Layfield LJ Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218 [TBL] [Abstract][Full Text] [Related]
9. Mutation of the epidermal growth factor receptor gene in the development of adenocarcinoma of the lung. Kozuki T; Hisamoto A; Tabata M; Takigawa N; Kiura K; Segawa Y; Nakata M; Mandai K; Eguchi K; Ueoka H; Tanimoto M Lung Cancer; 2007 Oct; 58(1):30-5. PubMed ID: 17561305 [TBL] [Abstract][Full Text] [Related]
10. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations. Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276 [TBL] [Abstract][Full Text] [Related]
11. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
13. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654 [TBL] [Abstract][Full Text] [Related]
14. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history. Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133 [TBL] [Abstract][Full Text] [Related]
15. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung. Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085 [TBL] [Abstract][Full Text] [Related]
17. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors. Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583 [TBL] [Abstract][Full Text] [Related]
18. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Kosaka T; Yatabe Y; Endoh H; Kuwano H; Takahashi T; Mitsudomi T Cancer Res; 2004 Dec; 64(24):8919-23. PubMed ID: 15604253 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung. Sartori G; Bettelli S; Schirosi L; Bigiani N; Maiorana A; Cavazza A; Rossi G Am J Surg Pathol; 2007 Oct; 31(10):1512-20. PubMed ID: 17895751 [TBL] [Abstract][Full Text] [Related]
20. Impact of epidermal growth factor receptor (EGFR) kinase mutations, EGFR gene amplifications, and KRAS mutations on survival of pancreatic adenocarcinoma. Lee J; Jang KT; Ki CS; Lim T; Park YS; Lim HY; Choi DW; Kang WK; Park K; Park JO Cancer; 2007 Apr; 109(8):1561-9. PubMed ID: 17354229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]